Qiao Yuxi, Yin Haobo, Zhang Yong, Zhang Jingdong, Dong Qian
Medical Oncology Department of Gastrointestinal Tumors, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Shenyang, China.
Pathology Department, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Shenyang, China.
Front Immunol. 2025 Aug 11;16:1585858. doi: 10.3389/fimmu.2025.1585858. eCollection 2025.
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a tumor microenvironment (TME) composed of a dense extracellular matrix, cancer-associated fibroblasts (CAFs), vasculature, neural elements, and immune cell populations. This complex network promotes tumor proliferation, invasion, metastasis, and resistance to immunotherapy and chemotherapy. The microenvironmental characteristics of the various PDAC subtypes are discussed in this review. And we examines the role of cancer cells in the TME, highlighting their ability to manipulate stromal components to serve as collaborators in tumor progression. Furthermore, we explored the formation mechanism of the immunosuppressive microenvironment in PDAC, paying attention on Inflammation and intrinsic genetic alterations, the regulatory effect of metabolic reprogramming, the contribution of CAFs and the role of immune cells in cancer cell metastasis. This review shows the role of soluble molecules and exosomes in facilitating PDAC progression and immune evasion within the microenvironment. In conclusion, we outline the novel therapeutic strategies that focus on the interaction between cancer cells and their microenvironment, with the objective of offering new insights for future precision medical interventions.
胰腺导管腺癌(PDAC)的特征是肿瘤微环境(TME),其由致密的细胞外基质、癌症相关成纤维细胞(CAF)、脉管系统、神经成分和免疫细胞群体组成。这种复杂的网络促进肿瘤增殖、侵袭、转移以及对免疫疗法和化疗的抗性。本综述讨论了各种PDAC亚型的微环境特征。并且我们研究了癌细胞在TME中的作用,强调它们操纵基质成分以在肿瘤进展中作为协同者的能力。此外,我们探讨了PDAC中免疫抑制微环境的形成机制,关注炎症和内在基因改变、代谢重编程的调节作用、CAF的贡献以及免疫细胞在癌细胞转移中的作用。本综述展示了可溶性分子和外泌体在促进微环境内PDAC进展和免疫逃逸中的作用。总之,我们概述了专注于癌细胞与其微环境之间相互作用的新型治疗策略,目的是为未来的精准医疗干预提供新见解。